Nu-Med Plus, Inc. Share Price

Equities

NUMD

US67021R1041

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 01:21:17 04/05/2024 am IST 5-day change 1st Jan Change
0.085 USD +27.06% Intraday chart for Nu-Med Plus, Inc. +70.00% +109.88%
Sales 2022 - Sales 2023 - Capitalization 3.38M 282M
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 -
Net Debt 2022 26.8K 2.23M Net Debt 2023 93.19K 7.77M EV / Sales 2023 -
P/E ratio 2022
-10.1 x
P/E ratio 2023
-26.3 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 54.96%
More Fundamentals * Assessed data
Dynamic Chart
Nu-Med Plus, Inc. completed the acquisition of Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner. CI
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Nu-Med Plus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Nu-Med Plus, Inc. entered into a letter of intent to acquire Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner. CI
Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Nu-Med Plus, Inc. Auditor Raises 'Going Concern' Doubt CI
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Nu-Med Plus, Inc. announced that it has received $0.1 million in funding from Your Space, Inc CI
Nu-Med Plus, Inc. Appoints Jeffrey L. Robins to the Board of Director CI
Nu-Med Plus, Inc. Announces Management Changes CI
Nu-Med Plus, Inc. Announces Management Changes CI
Nu-Med Plus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+27.06%
1 week+70.00%
Current month+31.17%
1 month+70.00%
3 months+183.33%
6 months+347.37%
Current year+109.88%
More quotes
1 week
0.05
Extreme 0.047
0.09
1 month
0.03
Extreme 0.0338
0.09
Current year
0.02
Extreme 0.02
0.09
1 year
0.01
Extreme 0.0116
0.09
3 years
0.01
Extreme 0.009
0.65
5 years
0.01
Extreme 0.009
2.50
10 years
0.01
Extreme 0.009
2.50
More quotes
Managers TitleAgeSince
Chairman 59 12/22/12
Director of Finance/CFO 78 01/15/01
Members of the board TitleAgeSince
Director of Finance/CFO 78 01/15/01
Chief Executive Officer 75 -
Chairman 59 12/22/12
More insiders
Date Price Change Volume
03/24/03 0.085 +27.06% 14,666
02/24/02 0.0669 +13.25% 156,087
01/24/01 0.0591 -8.83% 22,004
30/24/30 0.0648 +6.53% 4,915
29/24/29 0.0608 +21.66% 124,104

Delayed Quote OTC Markets, May 04, 2024 at 01:21 am IST

More quotes
Nu-Med Plus, Inc. is a medical device company, which is principally engaged in the designing, development, enhancement and commercialization of later-stage medical devices. The Company is focused on the creation of a nitric oxide generating formulation, a hospital bedside nitric oxide (NO) delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers high purity NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery provides a range of concentrations and flow rates of NO.
More about the company